China Anti-infective Agents Market Size & Outlook
China anti-infective agents market, 2018-2030 (US$M)
Related Markets
China anti-infective agents market highlights
- The China anti-infective agents market generated a revenue of USD 10,059.4 million in 2024 and is expected to reach USD 12,567.7 million by 2030.
- The China market is expected to grow at a CAGR of 3.9% from 2025 to 2030.
- In terms of segment, antibacterials was the largest revenue generating type in 2024.
- Antifungals is the most lucrative type segment registering the fastest growth during the forecast period.
Anti-infective agents market data book summary
| Market revenue in 2024 | USD 10,059.4 million |
| Market revenue in 2030 | USD 12,567.7 million |
| Growth rate | 3.9% (CAGR from 2025 to 2030) |
| Largest segment | Antibacterials |
| Fastest growing segment | Antifungals |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Antibacterials, Antivirals, Antifungals |
| Key market players worldwide | Pfizer Inc, Abbott Laboratories, Gilead Sciences Inc, Bristol-Myers Squibb Co, Merck & Co Inc, Sandoz Group AG ADR, B. Braun, Novo Holdings, Mankind Pharma, Bayer AG, AstraZeneca PLC, Boehringer Ingelheim Pharma |
Other key industry trends
- In terms of revenue, China accounted for 7.4% of the global anti-infective agents market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China anti-infective agents market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 8,841.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anti-infective Agents Market Scope
Anti-infective Agents Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China anti-infective agents market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anti-infective agents market will help companies and investors design strategic landscapes.
Antibacterials was the largest segment with a revenue share of 77.16% in 2024. Horizon Databook has segmented the China anti-infective agents market based on antibacterials, antivirals, antifungals covering the revenue growth of each sub-segment from 2018 to 2030.
China's anti-infective agents market is experiencing significant growth, driven by increased investments in research and development. The government is actively promoting initiatives to enhance innovation, leading to a surge in clinical trials for new anti-infective therapies.
Designed to combat infections from multidrug-resistant Gram-negative bacteria, MRX-8 met its anticipated objectives in this trial. This achievement marks an important milestone in the journey to establish MRX-8 as a safe and effective new antibacterial treatment.
Collaborations between pharmaceutical companies and research institutions are further bolstering the landscape, ensuring that China remains at the forefront of combating infectious diseases. In September 2024, BioVersys announced a strategic investment from GIBF2 and the initiation of its BV100 clinical program in China.
Reasons to subscribe to China anti-infective agents market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China anti-infective agents market databook
-
Our clientele includes a mix of anti-infective agents market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China anti-infective agents market , including forecasts for subscribers. This country databook contains high-level insights into China anti-infective agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China anti infective agents market size, by type, 2018-2030 (US$M)
China Anti-infective Agents Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
